XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 78,802 $ 97,413 $ 250,799 $ 301,170
Cost of sales 38,153 109,966 120,849 191,743
Gross profit (loss) 40,649 (12,553) 129,950 109,427
Operating expenses:        
Selling and marketing 27,620 30,731 91,786 112,471
Research and development 1,108 1,839 5,074 7,056
General and administrative 33,436 36,978 93,707 102,457
Total operating expenses 62,164 69,548 190,567 221,984
Loss from operations (21,515) (82,101) (60,617) (112,557)
Interest expense 2,468 3,445 7,949 10,291
Interest income (4,876) (6,750) (14,426) (16,782)
Other income, net (69) (4,872) (33,475) (5,337)
Change in fair value of warrant liabilities (418) (5,855) (2,997) (8,364)
Foreign currency transaction (gain) loss, net (2,277) 2,270 164 724
Loss before provision for income taxes (16,343) (70,339) (17,832) (93,089)
Income tax expense (benefit) 1,948 3,479 936 (2,376)
Net loss (18,291) (73,818) (18,768) (90,713)
Comprehensive loss, net of tax:        
Foreign currency translation adjustments 1,187 (1,093) (676) (572)
Comprehensive loss $ (17,104) $ (74,911) $ (19,444) $ (91,285)
Net loss per share        
Basic (in dollars per share) $ (0.15) $ (0.56) $ (0.15) $ (0.68)
Diluted (in dollars per share) $ (0.15) $ (0.56) $ (0.31) $ (0.68)
Weighted average common stock outstanding        
Basic (in shares) 124,057,602 132,896,626 123,630,811 132,679,547
Diluted (in shares) 124,057,602 132,896,626 142,667,209 132,679,547